Facebook Pixel
Pluto Money Logo
Pluto Money Logo
Cipla Limited

Cipla Limited (CIPLA)

1,504.3

INR
+14.50(+0.97%)
As of June 6, 2025 9:54:00 AM

About Cipla Limited

Cipla Ltd., a renowned name in the pharmaceutical industry, primarily focuses on the development and manufacturing of a wide array of medicines essential for treating diseases across various therapeutic fields. Known for its generic and branded formulations, Cipla delivers healthcare solutions in areas such as respiratory ailments, anti-retrovirals, urology, and cardiovascular diseases, among others. With a core emphasis on affordable medication, Cipla significantly contributes to improving global health standards, particularly in developing regions where access to expensive treatments is limited. Established in India and expanding its reach across multiple international markets, Cipla plays a pivotal role in the pharmaceutical landscape, exemplifying quality, innovation, and social responsibility. By leveraging cutting-edge research and development, Cipla not only enhances its competitive edge but also fosters advancements in drug manufacturing processes, making it a key player in the healthcare sector's ongoing evolution.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
4.43
Operating MarginLast 12 months
18.63
+30.099999999999998% quarterly YoY
Market Cap
120354.24 CrINR
Employees
27764
CEO
Mr. Umang Vohra B.E., M.B.A.
Website
©2025 Pluto Money All Rights Reserved.